Skip to main content
. 2018 Feb 20;9(3):136. doi: 10.1038/s41424-018-0006-7

Fig. 4. The Kaplan–Meier estimator graphs showing the cumulative relapse-free rates for patients with high and low fecal biomarkers.

Fig. 4

The relapse-free rate was significantly higher in patients with low fecal biomarkers compared with those who had elevated biomarkers (all P < 0.0001)